Related Experiment Videos
Idiopathic intracranial hypertension
Devin K Binder1, Jonathan C Horton, Michael T Lawton
1Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143-0112, USA.
Neurosurgery
|March 19, 2004
Summary
Idiopathic intracranial hypertension (IIH), previously known as pseudotumor cerebri, requires prompt diagnosis and treatment to prevent vision loss. This review covers its history, diagnosis, and therapeutic strategies.
Area of Science:
- Neurology
- Ophthalmology
Background:
- Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a condition characterized by increased intracranial pressure without a clear cause.
- Understanding the history and pathogenesis of IIH is crucial for effective management.
Purpose of the Study:
- To review the history, diagnosis, pathogenesis, clinical presentation, and therapeutic challenges of idiopathic intracranial hypertension.
- To provide a comprehensive overview of current diagnostic criteria and treatment modalities for IIH.
Main Methods:
- Extensive literature review of idiopathic intracranial hypertension and related conditions.
- Analysis of historical data, diagnostic criteria, and treatment outcomes.
- Synthesis of information on medical and surgical interventions.
Main Results:
- Diagnosis relies on modified Dandy criteria, excluding secondary causes of intracranial hypertension.
- Common symptoms include headaches and papilledema; visual loss is a primary concern.
- Therapeutic options include medical management (e.g., carbonic anhydrase inhibitors, weight loss) and surgical interventions (e.g., shunting, optic nerve fenestration).
Conclusions:
- Idiopathic intracranial hypertension is the preferred term, replacing pseudotumor cerebri.
- IIH is a diagnosis of exclusion requiring thorough evaluation.
- Timely diagnosis and comprehensive treatment are essential to preserve vision and alleviate symptoms.